Myeloid-derived suppressor cells are key players in the resolution of inflammation during a model of acute infection

European Journal of Immunology

Volumn 44, Issue 1, 2014, Pages 184-194

  Arocena, Alfredo R ^a   Onofrio, Luisina I ^a   Pellegrini, Andrea V ^a   Carrera Silva, Antonio E ^b   Paroli, Augusto ^a   Cano, Roxana C ^a   Aoki, Maria P ^a   Gea, Susana ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; MDSCs; Nitric oxide; ROS; Trypanosoma cruzi

Indexed keywords

CD11B ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 6; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; CYTOKINE; NEUTROPHIL CYTOSOLIC FACTOR 1; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL SURFACE; CELLULAR IMMUNITY; CHAGAS DISEASE; CONTROLLED STUDY; INFECTION; INFLAMMATION; MORTALITY; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL; SUPPRESSOR CELL; SURVIVAL; TH17 CELL; TRYPANOSOMA CRUZI; UPREGULATION; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; COMPARATIVE STUDY; DISEASE MODEL; GENETICS; GRANULOCYTE; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHAGAS DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; GRANULOCYTES; HUMANS; IMMUNOSUPPRESSION; INFLAMMATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; STAT3 TRANSCRIPTION FACTOR; TH17 CELLS; TRYPANOSOMA CRUZI;

EID: 84892471724     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343606     Document Type: Article

References (49)

1. Talmadge, J. E., Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy. Clin. Cancer Res. 2007. 13: 5243-5248.
2. Gabrilovich, D. I., Ostrand-Rosenberg, S. and Bronte, V., Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 2012. 12: 253-268.
3. Gabrilovich, D. I. and Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009. 9: 162-174.
4. Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P. et al., Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008. 111: 4233-4244.
5. Youn, J. I., Collazo, M., Shalova, I. N., Biswas, S. K. and Gabrilovich, D. I., Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol. 2012. 91: 167-181.
6. Brandau, S., Trellakis, S., Bruderek, K., Schmaltz, D., Steller, G., Elian, M., Suttmann, H. et al., Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J. Leukoc. Biol. 2011. 89: 311-317.
7. Ostrand-Rosenberg, S. and Sinha, P., Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 2009. 182: 4499-4506.
8. Srivastava, M. K., Sinha, P., Clements, V. K., Rodriguez, P. and Ostrand-Rosenberg, S., Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res. 2010. 70: 68-77.
9. Apolloni, E., Bronte, V., Mazzoni, A., Serafini, P., Cabrelle, A., Segal, D. M., Young, H. A. et al., Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. J. Immunol. 2000. 165: 6723-6730.
10. Cuervo, H., Guerrero, N. A., Carbajosa, S., Beschin, A., De Baetselier, P., Girones, Fresno, M., Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection. J. Immunol. 2011. 187: 2656-2665.
11. Huang, B., Pan, P. Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C.M. et al., Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 2006. 66: 1123-1131.
12. Li, H., Han, Y., Guo, Q., Zhang, M. and Cao, X., Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1. J. Immunol. 2009. 182: 240-249.
13. Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P. et al., Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 2008. 13: 23-35.
14. Rodriguez, P. C., Hernandez, C. P., Quiceno, D., Dubinett, S. M., Zabaleta, J., Ochoa, J. B., Gilbert, J. et al., Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J. Exp. Med. 2005. 202: 931-939.
15. Marigo, I., Dolcetti, L., Serafini, P., Zanovello, P. and Bronte, V., Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol. Rev. 2008. 222: 162-179.
16. Ostrand-Rosenberg, S., Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity. Cancer Immunol. Immunother. 2010. 59: 1593-1600.
17. Schmunis, G. A. and Yadon, Z. E., Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 2010. 115: 14-21.
18. Bouzahzah, B., Nagajyothi, F., Desruisseaux, M. S., Krishnamachary, Factor, S. M., Cohen, A. W., Lisanti, M. P. et al., Cell cycle regulatory proteins in the liver in murine Trypanosoma cruzi infection. Cell Cycle 2006. 5: 2396-2400.
19. Sardinha, L. R., Elias, R. M., Mosca, T., Bastos, K. R., Marinho, C. R., D'Império Lima, M. R., Alvarez, J. M., Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi. Infect. Immun. 2006. 74: 2031-2042.
20. Ronco, M. T., Frances, D. E., Ingaramo, P. I., Quiroga, A. D., Alvarez, M. L., Pisani G. B., Revelli, S. S., et al., Tumor necrosis factor alpha induced by Trypanosoma cruzi infection mediates inflammation and cell death in the liver of infected mice. Cytokine 2010. 49: 64-72.
21. Carrera-Silva, E. A., Guinazu, N., Pellegrini, A., Cano, R. C., Arocena, A., Aoki, M. P., Gea, S., Importance of TLR2 on hepatic immune and non-immune cells to attenuate the strong inflammatory liver response during Trypanosoma cruzi acute infection. PLoS Negl. Trop. Dis. 2010. 4: e863.
22. Goni, O., Alcaide, P. and Fresno, M., Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+)immature myeloid suppressor cells. Int. Immunol. 2002. 14: 1125-1134.
23. Carrera-Silva, E. A., Cano, R. C., Guinazu, N., Aoki, M. P., Pellegrini, A. and Gea, S., TLR2, TLR4 and TLR9 are differentially modulated in liver lethally injured from BALB/c and C57BL/6 mice during Trypanosoma cruzi acute infection. Mol. Immunol. 2008. 45: 3580-3588.
24. Dworakowski, R., Anilkumar, N., Zhang, M. and Shah, A. M., Redox signalling involving NADPH oxidase-derived reactive oxygen species. Biochem. Soc. Trans. 2006. 34: 960-964.
25. Cheng, L., Wang, J., Li, X., Xing, Q., Du, P., Su, L. and Wang, S., Interleukin-6 induces Gr-1+CD11b +myeloid cells to suppress CD8+ T cell-mediated liver injury in mice. PLoS One 2011. 6: e17631.
26. Chalmin, F., Ladoire, S., Mignot, G., Vincent, J., Bruchard, M., Remy-Martin, J. P., Boireau, W. et al., Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J. Clin. Invest. 2010. 120: 457-471.
27. Corzo, C. A., Cotter, M. J., Cheng, P., Cheng, F., Kusmartsev, Sotomayor, E., Padhya, T. et al., Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J. Immunol. 2009. 182: 5693-5701.
28. Vincent, J., Mignot, G., Chalmin, F., Ladoire, S., Bruchard, M., Chevriaux, A., Martin, F. et al., 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. Cancer Res. 2010. 70: 3052-3061.
29. Betts, M. R., Brenchley, J. M., Price, D. A., De Rosa, S. C., Douek, Roederer, M., Koup, R. A., Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 2003. 281: 65-78.
30. Mishra, P. K., Morris, E. G., Garcia, J. A., Cardona, A. A. and Teale, J. M., Increased accumulation of regulatory granulocytic myeloid cells in mannose receptor C type 1 deficient mice correlates with protection in mouse model of NCC. Infect. Immun. 2013. 81: 1052-1063.
31. Ioannou, M., Alissafi, T., Lazaridis, I., Deraos, G., Matsoukas, Gravanis, A., Mastorodemos, V., Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease. J. Immunol. 2012. 188: 1136-1146.
32. Su, H., Cong, X. and Liu, Y. L., Transplantation of granulocytic myeloid derived suppressor cells (G-MDSCs) could reduce colitis in experimental murine models. J. Dig. Dis. 2013. 14: 251-258.
33. Knubel, C. P., Martinez, F. F., Acosta Rodriguez, E. V., Altamirano, A., Rivarola, H. W., Diaz Luján, C., Fretes, R. E. et al., 3-Hydroxy kynurenine treatment controls T. cruzi replication and the inflammatory pathology preventing the clinical symptoms of chronic Chagas disease. PLoS One 2011. 6: e26550.
34. Andrade, D., Serra, R., Svensjö, E., Lima, A. P., Ramos, E. S. J., Fortes, F. S., Morandini, A.C. et al., Trypanosoma cruzi invades host cells through the activation of endothelin and bradykinin receptors: a converging pathway leading to chagasic vasculopathy. Br. J. Pharmacol. 2012 165: 1333-1347.
35. Youn, J. I., Nagaraj, S., Collazo, M. and Gabrilovich, D. I., Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 2008. 181: 5791-5802.
36. Sinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M. and Ostrand-Rosenberg, S., Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J. Immunol. 2007. 179: 977-983.
37. Cuervo, H., Pineda, M. A., Aoki, M. P., Gea, S., Fresno, M. and Girones, N., Inducible nitric oxide synthase and arginase expression in heart tissue during acute Trypanosoma cruzi infection in mice: arginase I is expressed in infiltrating CD68 +macrophages. J. Infect. Dis. 2008. 197: 1772-1782.
38. Nefedova, Y., Huang, M., Kusmartsev, S., Bhattacharya, R., Cheng, P., Salup, R., Jove, R. et al., Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. J. Immunol. 2004. 172: 464-474.
39. Nefedova, Y., Nagaraj, S., Rosenbauer, A., Muro-Cacho, C., Sebti, S. M. and Gabrilovich, D. I., Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway. Cancer Res. 2005. 65: 9525-9535.
40. Poschke, I., Mougiakakos, D., Hansson, J., Masucci, G. V. and Kiessling, R., Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res. 2010. 70: 4335-4345.
41. Nagaraj, S., Gupta, K., Pisarev, V., Kinarsky, L., Sherman, S., Kang, L., Herber, D. L. et al., Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat. Med. 2007. 13: 828-835.
42. Wu, C. T., Hsieh, C. C., Lin, C. C., Chen, W. C., Hong, J. H. and Chen, M. F., Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells. J. Mol. Med. 2012. 90: 1343-1355.
43. Lopes, M. F. and DosReis, G. A., Trypanosoma cruzi induced immunosuppression: selective triggering of CD4+ T-cell death by the T-cell receptor-CD3 pathway and not by the CD69 or Ly-6 activation pathway. Infect. Immun. 1996. 64: 1559-1564.
44. Romani, L., Fallarino, F., De Luca, A., Montagnoli, C., D'Angelo, C., Zelante, T., Vacca, C. et al., Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 2008. 451: 211-215.
45. Srivastava, M. K., Dubinett, S. and Sharma, S., Targeting MDSCs enhance therapeutic vaccination responses against lung cancer. Oncoimmunology 2012. 1: 1650-1651.
46. Cuenca, A. G., Delano, M. J., Kelly-Scumpia, K. M., Moreno, L. L., Scumpia, P. O., Laface, D. M., Heyworth, P. G. et al., A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol. Med. 2011. 17: 281-292.
47. Jiao, Z., Hua, S., Wang, W., Wang, H., Gao, J. and Wang, X., Increased circulating myeloid-derived suppressor cells correlated negatively with Th17 cells in patients with rheumatoid arthritis. Scand. J. Rheumatol. 2013. 42: 85-90.
48. Yi, H., Guo, C., Yu, X., Zuo, D. and Wang, X. Y., Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis. J. Immunol. 2012. 189: 4295-4304.
49. Alter, G., Malenfant, J. M. and Altfeld, M., CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 2004. 294: 15-22.